Association between periconceptional supplementation of folic acid or multiple-micronutrients containing folic acid and preterm delivery in women

  • Yin-xiao BAI ,
  • Chun-yi LIU ,
  • Jie ZHANG ,
  • Wen-ying MENG ,
  • Lei JIN ,
  • Lei JIN
Expand
  • 1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
    2. Institute of Reproductive and Child Health, Peking University, Beijing 100191, China
    3. National Health Commission Key Laboratory of Reproductive Health, Beijing 100191, China
    4. Department of Obstetrics, Tongzhou Maternal and Child Health Hospital of Beijing, Beijing 101100, China
    5. Department of Maternal Health Care, Tongzhou Maternal and Child Health Hospital of Beijing, Beijing 101100, China

Received date: 2022-11-23

  Online published: 2023-06-12

Supported by

the Capital Health Research and Development of Special(2020-1-5112);the National Social Science Fund of China(21&ZD187)

Abstract

Objective: To explore the association between periconceptional supplementation of folic acid or multiple-micronutrients containing folic acid(MMFA) and risk of preterm delivery in women with natural conception, singleton pregnancy and vaginal delivery. Methods: A retrospective cohort study was performed based on the prenatal health care system and hospital information system of Tongzhou Maternal and Child Health Hospital of Beijing and the women who had their prenatal care in the hospital from January 2015 to December 2018 were included. The information of 16 332 women who conceived naturally, had a singleton pregnancy, and delivered vaginally was collected. Compliance scores were constructed based on the time of initiation and the frequency of taking nutritional supplements. The association between maternal periconceptional micronutrient supplementation, including pure folic acid (FA) pills or MMFA and the rate of preterm delivery was evaluated using Logistic regression models. Results: The preterm delivery rate (gestational week < 37 weeks) of the study population was 3.8%, and the mean (standard deviation) of gestational age was (38.98±1.37) weeks. A total of 6 174 (37.8%) women took FA during the periconceptional period, 8 646 (52.9%) women took MMFA, and 1 512 (9.3%) women did not take any nutritional supplements. The association between periconceptional supplementation of FA or MMFA and risk of preterm delivery in women was not statistically significant [adjusted odds ratio (aOR)=1.01, 95%CI: 0.74-1.37]. The associations with preterm birth were not statistically significant in further analysis by the type of nutritional supplements, time of initiation, and the frequency of supplementation. In addition, the association between the compliance score of taking supplements and the rate of preterm delivery was not statistically significant, either. Conclusion: This study did not find an association between the risk of preterm delivery and the use of FA or MMFA during the periconcep-tional period in women with natural conception, singleton pregnancy, and vaginal delivery. In the future, multicenter studies with large-scale prospective cohort or population-based randomized controlled trials are warranted to confirm the association between taking FA or MMFA during the periconceptional period and preterm delivery among women.

Cite this article

Yin-xiao BAI , Chun-yi LIU , Jie ZHANG , Wen-ying MENG , Lei JIN , Lei JIN . Association between periconceptional supplementation of folic acid or multiple-micronutrients containing folic acid and preterm delivery in women[J]. Journal of Peking University(Health Sciences), 2023 , 55(3) : 495 -501 . DOI: 10.19723/j.issn.1671-167X.2023.03.016

References

1 Blencowe H , Cousens S , Oestergaard MZ , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A systematic analysis and implications[J]. Lancet, 2012, 379 (9832): 2162- 2172.
2 Deng K , Liang J , Mu Y , et al. Preterm births in China between 2012 and 2018: An observational study of more than 9 million women[J]. Lancet Glob Health, 2021, 9 (9): e1226- e1241.
3 March of Dimes; Partnership for Maternal, Newborn Child Health; Save the Children; World Health Organization. Born too soon: The global action report on preterm birth [R]. Geneva: WHO, 2012.
4 WHO. Preterm birth [EB/OL]. (2018-02-19) [2022-11-13]. https://www.who.int/news-room/fact-sheets/detail/preterm-birth.
5 D'Agata AL , Green CE , Sullivan MC . A new patient population for adult clinicians: Preterm born adults[J]. Lancet Reg Health Am, 2022, 9, 100188.
6 Tamura T , Picciano MF . Folate and human reproduction[J]. Am J Clin Nutr, 2006, 83 (5): 993- 1016.
7 Gernand AD , Schulze KJ , Stewart CP , et al. Micronutrient deficiencies in pregnancy worldwide: Health effects and prevention[J]. Nat Rev Endocrinol, 2016, 12 (5): 274- 289.
8 Keats EC , Haider BA , Tam E , et al. Multiple-micronutrient supplementation for women during pregnancy[J]. Cochrane Database Syst Rev, 2019, 3 (3): CD004905.
9 Wang D , Jin L , Zhang J , et al. Maternal periconceptional folic acid supplementation and risk for fetal congenital heart defects[J]. J Pediatr, 2022, 240, 72- 78.
10 Berry RJ , Li Z , Erickson JD , et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention[J]. N Engl J Med, 1999, 341 (20): 1485- 1490.
11 Jonker H , Capelle N , Lanes A , et al. Maternal folic acid supplementation and infant birthweight in low- and middle-income countries: A systematic review[J]. Matern Child Nutr, 2020, 16 (1): e12895.
12 Lin J , Wang C , Li S , et al. Periconceptional folic acid supplementation and newborn birth weights[J]. Front Pediatr, 2022, 10, 844404.
13 Partap U , Chowdhury R , Taneja S , et al. Preconception and periconception interventions to prevent low birth weight, small for gestational age and preterm birth: A systematic review and meta-analysis[J]. BMJ Glob Health, 2022, 7 (8): e007537.
14 Wolf HT , Hegaard HK , Huusom LD , et al. Multivitamin use and adverse birth outcomes in high-income countries: A systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2017, 217 (4): 404. e1- 404. e30.
15 Keats EC , Oh C , Chau T , et al. Effects of vitamin and mineral supplementation during pregnancy on maternal, birth, child health and development outcomes in low- and middle-income countries: A systematic review[J]. Campbell Syst Rev, 2021, 17 (2): e1127.
16 金蕾, 王程, 张杰, 等. 妇女围受孕期叶酸服用情况及其对胎儿神经管缺陷的预防效果[J]. 北京大学学报(医学版), 2020, 52 (4): 719- 725.
17 Steegers-Theunissen RP , Twigt J , Pestinger V , et al. The periconceptional period, reproduction and long-term health of offspring: The importance of one-carbon metabolism[J]. Hum Reprod Update, 2013, 19 (6): 640- 655.
18 ACOG Committee Opinion No 579: Definition of term pregnancy [J]. Obstet Gynecol, 2013, 122(5): 1139-1140.
19 孙长颢. 营养与食品卫生学[M]. 8版 北京: 人民卫生出版, 2017: 93- 95. 93-95, 215
20 Saccone G , Berghella V . Folic acid supplementation in pregnancy to prevent preterm birth: A systematic review and meta-analysis of randomized controlled trials[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 199, 76- 81.
21 Zheng JS , Guan Y , Zhao Y , et al. Pre-conceptional intake of folic acid supplements is inversely associated with risk of preterm birth and small-for-gestational-age birth: A prospective cohort study[J]. Br J Nutr, 2016, 115 (3): 509- 516.
22 Maas VYF , Poels M , Lamain-de Ruiter M , et al. Associations between periconceptional lifestyle behaviours and adverse pregnancy outcomes[J]. BMC Pregnancy Childbirth, 2021, 21 (1): 492.
23 Li Z , Ye R , Zhang L , et al. Periconceptional folic acid supplementation and the risk of preterm births in China: A large prospective cohort study[J]. Int J Epidemiol, 2014, 43 (4): 1132- 1139.
24 Wu Y , Yuan Y , Kong C , et al. The association between periconceptional folic acid supplementation and the risk of preterm birth: A population-based retrospective cohort study of 200, 000 women in China[J]. Eur J Nutr, 2021, 60 (4): 2181- 2192.
25 Dai C , Fei Y , Li J , et al. A novel review of homocysteine and pregnancy complications[J]. Biomed Res Int, 2021, 2021, 6652231.
Outlines

/